Founded in 1993, BTL is a leading developer and manufacturer of medical devices. Its primary segments include cardiology, such as holter monitoring and stress test systems, pneumology, physical therapy, and medical aesthetics. BTL’s medical aesthetic line includes non-invasive body shaping technologies for fat cell disruption and body sculpting, as well as advanced systems for skin tightening, cellulite treatment, hair removal and facial therapies. BTL makes its worldwide marketing efforts through direct sales subsidiaries located in over 50 countries on 4 continents, as well as through a network of independent distributors. BTL has a worldclass ISO 13485 certified quality system, and is GMP compliant. Many of its products bear CE mark, are US FDA cleared and Health Canada licensed.